Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Easterly Government Properties Reports First Quarter 2019 Results

Published

on

Reading Time: 12 minutes

WASHINGTON–(BUSINESS WIRE)–Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or
“Easterly”), a fully integrated real estate investment trust (“REIT”)
focused primarily on the acquisition, development and management of
Class A commercial properties leased to the U.S. Government, today
announced its results of operations for the quarter ended March 31, 2019.

Highlights for the Quarter Ended March 31, 2019:

  • Net loss of $0.5 million, or $0.01 per share on a fully diluted basis
  • FFO of $22.0 million, or $0.31 per share on a fully diluted basis
  • FFO, as Adjusted of $20.8 million, or $0.29 per share on a fully
    diluted basis
  • CAD of $18.5 million
  • Completed the acquisition of the final three of the 14 properties in
    the Company’s previously announced portfolio acquisition. The three
    properties represent an aggregate of 355,426 square feet and were
    acquired for a combined purchase price of $152.5 million
  • Issued 6.7 million shares of common stock in exchange for
    approximately $119.2 million in gross proceeds, settling a portion of
    the forward sales agreements entered into in connection with the June
    2018 underwritten public offering of 20.7 million shares of the
    Company’s common stock
  • Launched a new ATM program pursuant to which the Company may issue and
    sell shares of common stock having an aggregate offering price of up
    to $200.0 million including through the sale of shares on a forward
    basis (“2019 ATM Program”)
  • Maintained portfolio occupancy at 100%

“Easterly is a company built on secure, recurring cash flows backed by
the full faith and credit of our largest tenant, the U.S. Government,”
said William C. Trimble, III, Easterly’s Chief Executive Officer. “We
believe the underlying credit quality of our 100% leased portfolio
provides for superior risk adjusted returns.”

Financial Results for the Quarter Ended March 31, 2019:

Net loss of $0.5 million, or $0.01 per share on a fully diluted basis

FFO of $22.0 million, or $0.31 per share on a fully diluted basis

FFO, as Adjusted of $20.8 million, or $0.29 per share on a fully diluted
basis

CAD of $18.5 million

Portfolio Operations

As of March 31, 2019, the Company wholly owned 65 operating properties
in the United States, encompassing approximately 5.6 million square feet
in the aggregate, including 63 operating properties that were leased
primarily to U.S. Government tenant agencies and two operating
properties that were entirely leased to private tenants. As of March 31,
2019, the portfolio had a weighted average age of 13.0 years, based upon
the date the property was built or renovated-to-suit, was 100% occupied,
and had a weighted average remaining lease term of 7.3 years.

Acquisitions and Development Activities

On January 31, 2019, the Company completed the acquisition of the final
three of the 14 properties in the Company’s previously announced
portfolio acquisition. The three properties represent an aggregate of
355,426 square feet and were acquired for a combined purchase price of
$152.5 million. The three properties include:

  • DEA – Sterling, VA

    DEA – Sterling serves as a
    special testing and research laboratory to assist the Drug Enforcement
    Administration (DEA) in performing mission critical forensic analyses.
    The 49,692-square foot facility was built-to-suit in 2001 and includes
    evidence rooms, computer labs, cryptography and various other
    specialized laboratories. The facility is 100% leased through 2020.

  • FDA – College Park, MD

    FDA – College Park houses a
    laboratory for the Food and Drug Administration’s (FDA) Center for
    Food Safety and Applied Nutrition (CFSAN), one of the FDA’s seven
    product-oriented centers. The 80,677-square foot office and laboratory
    was built-to-suit in 2004 and is 100% leased through 2029. The
    facility is part of the University of Maryland’s Research Park and is
    located two blocks from CFSAN headquarters in the Harvey W. Wiley
    Building, forming a campus which links university researchers,
    students and staff with federal laboratories and private sector
    companies.

  • Various GSA – Portland, OR

    Various GSA – Portland, a
    Class A trophy multi-tenanted asset, was built in 2002 and is
    strategically located within Portland’s Central City Plan District
    along the MAX light rail system. The 225,057-square foot facility is
    occupied by tenants such as the U.S. Department of Agriculture (USDA),
    U.S. Army Corp of Engineers (ACOE), Federal Bureau of Investigation
    (FBI) and the Bureau of Alcohol, Tobacco, Firearms and Explosives
    (ATF).

Balance Sheet and Capital Markets Activity

As of March 31, 2019, the Company had total indebtedness of $819.8
million comprised of $184.5 million outstanding on its revolving credit
facility, $150.0 million outstanding on its 2018 term loan facility,
$100.0 million outstanding on its 2016 term loan facility, $175.0
million of senior unsecured notes, and $210.3 million of mortgage debt
(excluding unamortized premiums and discounts and deferred financing
fees). At March 31, 2019, Easterly’s outstanding debt had a weighted
average maturity of 6.2 years and a weighted average interest rate of
3.7%. As of March 31, 2019, Easterly’s Net Debt to total enterprise
value was 36.6% and its Net Debt to annualized quarterly EBITDA and
Adjusted Net Debt to annualized quarterly pro-forma EBITDA ratios were
6.7x and 6.1x, respectively.

On March 4, 2019, the Company launched its 2019 ATM Program, pursuant to
which the Company may issue and sell shares of common stock having an
aggregate offering price of up to $200.0 million from time to time in
negotiated transactions or transactions that are deemed to be
“at-the-market” offerings through the applicable sales agents. Under the
2019 ATM Program, the Company may also enter into one or more forward
transactions under separate master forward sale confirmations and
related supplemental confirmations with certain sales agents or their
affiliates for the sale of shares of common stock on a forward basis.

During the quarter ended March 31, 2019, the Company issued 366,455
shares of the Company’s common stock at a weighted average price of
$17.93 per share through the Company’s previously existing ATM program,
raising gross proceeds of approximately $6.6 million to maintain balance
sheet strength.

Dividend

On May 2, 2019, the Board of Directors of Easterly approved a cash
dividend for the first quarter of 2019 in the amount of $0.26 per common
share. The dividend will be payable June 27, 2019 to shareholders of
record on June 10, 2019.

Outlook for the 12 Months Ending December 31,
2019

The Company is reiterating its guidance for 2019 FFO per share on a
fully diluted basis in a range of $1.16 – $1.20.

                 
Low High
Net income (loss) per share – fully diluted basis $ 0.04   0.08
Plus: real estate depreciation and amortization $ 1.12 1.12
FFO per share – fully diluted basis $ 1.16 1.20
 

This guidance assumes $200 million of acquisitions, not including the Q1
2019 closings of the final three properties in the 14-property
portfolio, and $75 – $100 million of gross development-related
investment during 2019.

The Company’s guidance for 2019 FFO per share on a fully diluted basis
represents expected FFO, as Adjusted per share on a fully diluted basis
growth of approximately 6% to 11%.

This guidance is forward-looking and reflects management’s view of
current and future market conditions. The Company’s actual results may
differ materially from this guidance.

Non-GAAP Supplemental Financial Measures

This section contains definitions of certain non-GAAP financial
measures and other terms that the Company uses in this press release
and, where applicable, the reasons why management believes these
non-GAAP financial measures provide useful information to investors
about the Company’s financial condition and results of operations and
the other purposes for which management uses the measures. These
measures should not be considered in isolation or as a substitute for
measures of performance in accordance with GAAP. Additional detail can
be found in the Company’s most recent annual report on Form 10-K and
quarterly report on Form 10-Q, as well as other documents filed with or
furnished to the SEC from time to time.

Cash Available for Distribution (CAD) is a non-GAAP financial
measure that is not intended to represent cash flow for the period and
is not indicative of cash flow provided by operating activities as
determined under GAAP. CAD is calculated in accordance with the current
Nareit definition as FFO minus normalized recurring real estate-related
expenditures and other non-cash items and nonrecurring expenditures. CAD
is presented solely as a supplemental disclosure because the Company
believes it provides useful information regarding the Company’s ability
to fund its dividends. Because all companies do not calculate CAD the
same way, the presentation of CAD may not be comparable to similarly
titled measures of other companies.

EBITDA is calculated as the sum of net income (loss) before
interest expense, income taxes, depreciation and amortization. EBITDA is
not intended to represent cash flow for the period, is not presented as
an alternative to operating income as an indicator of operating
performance, should not be considered in isolation or as a substitute
for measures of performance prepared in accordance with GAAP is not
indicative of operating income or cash provided by operating activities
as determined under GAAP and may be presented on a pro forma basis.
EBITDA is presented solely as a supplemental disclosure with respect to
liquidity because the Company believes it provides useful information
regarding the Company’s ability to service or incur debt. Because all
companies do not calculate EBITDA the same way, the presentation of
EBITDA may not be comparable to similarly titled measures of other
companies.

Funds From Operations (FFO) is defined, in accordance with the
Nareit FFO White Paper – 2018 Restatement as net income (loss),
calculated in accordance with GAAP, excluding depreciation and
amortization related to real estate, gains and losses from the sale of
certain real estate assets, gains and losses from change in control and
impairment write-downs of certain real estate assets and investments in
entities when the impairment is directly attributable to decreases in
the value of depreciable real estate held by the entity. FFO is a widely
recognized measure of REIT performance. Although FFO is a non-GAAP
financial measure, the Company believes that information regarding FFO
is helpful to shareholders and potential investors.

Funds From Operations, as Adjusted (FFO, as Adjusted) adjusts FFO
to present an alternative measure of our operating performance, which,
when applicable, excludes the impact of acquisition costs, straight-line
rent, above-/below-market leases, non-cash interest expense, non-cash
compensation and other non-cash items. By excluding these income and
expense items from FFO, as Adjusted, the Company believes it provides
useful information as these items have no cash impact. In addition, by
excluding acquisition related costs the Company believes FFO, as
Adjusted provides useful information that is comparable across periods
and more accurately reflects the operating performance of the Company’s
properties.

Net Debt and Adjusted Net Debt. Net Debt represents
consolidated debt (reported in accordance with GAAP) adjusted to exclude
unamortized premiums and discounts and deferred financing fees, less
cash and cash equivalents. By excluding these items, the result provides
an estimate of the contractual amount of borrowed capital to be repaid,
net of cash available to repay it. The Company believes this calculation
constitutes a beneficial supplemental non-GAAP financial disclosure to
investors in understanding its financial condition. Adjusted Net Debt is
Net Debt reduced by 1) the lesser of i) anticipated lump-sum
reimbursement amounts and ii) the cost to date for each project under
construction and 2) 40% times the amount by which the cost to date
exceeds anticipated lump-sum reimbursement amounts for each project
under construction. These adjustments are made to 1) remove the
estimated portion of each project under construction that has been
financed with debt which may be repaid with anticipated cost
reimbursement payments from the US Government and 2) remove the
estimated portion of each project under construction, in excess of
anticipated lump-sum reimbursements, that has been financed with debt
but has not yet produced earnings. See page 19 of the Company’s Q1 2019
Supplemental Information Package for further information. The Company’s
method of calculating Net Debt and Adjusted Net Debt may be different
from methods used by other REITs and, accordingly, may not be comparable
to such other REITS.

Other Definitions

Fully diluted basis assumes the exchange of all outstanding
common units representing limited partnership interests in the Company’s
operating partnership, the full vesting of all shares of restricted
stock, and the exchange of all earned and vested LTIP units in the
Company’s operating partnership for shares of common stock on a
one-for-one basis, which is not the same as the meaning of “fully
diluted” under GAAP.

Conference Call Information

The Company will host a webcast and conference call at 10:00 a.m.
Eastern Standard time on May 7, 2019 to review the first quarter 2019
performance, discuss recent events and conduct a question-and-answer
session. The number to call is 1-877-705-6003 (domestic) and
1-201-493-6725 (international). A live webcast will be available in the
Investor Relations section of the Company’s website. A replay of the
conference call will be available through May 21, 2019 by dialing
844-512-2921 (domestic) and 1-412-317-6671 (international) and entering
the passcode 13689856. Please note that the full text of the press
release and supplemental information package are available through the
Company’s website at ir.easterlyreit.com.

About Easterly Government Properties, Inc.

Easterly Government Properties, Inc. (NYSE:DEA) is based in Washington,
D.C., and focuses primarily on the acquisition, development and
management of Class A commercial properties that are leased to the U.S.
Government. Easterly’s experienced management team brings specialized
insight into the strategy and needs of mission-critical U.S. Government
agencies for properties leased to such agencies either directly or
through the U.S. General Services Administration (GSA). For further
information on the company and its properties, please visit www.easterlyreit.com.

Forward Looking Statements

We make statements in this press release that are considered
“forward-looking statements” within the meaning of Section 27A of the
Securities Act of 1933, as amended, or the Securities Act, and Section
21E of the Securities Exchange Act of 1934, as amended, or the Exchange
Act, which are usually identified by the use of words such as
“anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,”
“plans,” “projects,” “seeks,” “should,” “will,” and variations of such
words or similar expressions and include our guidance with respect to
Net income (loss) and FFO per share on a fully diluted basis.
We
intend these forward-looking statements to be covered by the safe harbor
provisions for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995 and are including this
statement in this press release for purposes of complying with those
safe harbor provisions. These forward-looking statements reflect our
current views about our plans, intentions, expectations, strategies and
prospects, which are based on the information currently available to us
and on assumptions we have made.
Although we believe that our
plans, intentions, expectations, strategies and prospects as reflected
in or suggested by those forward-looking statements are reasonable, we
can give no assurance that the plans, intentions, expectations or
strategies will be attained or achieved.
Furthermore, actual
results may differ materially from those described in the
forward-looking statements and will be affected by a variety of risks
and factors that are beyond our control including, without limitation:
risks associated with our dependence on the U.S. Government and its
agencies for substantially all of our revenues; risks associated with
ownership and development of real estate; the risk of decreased rental
rates or increased vacancy rates; loss of key personnel; general
volatility of the capital and credit markets and the market price of our
common stock; the risk we may lose one or more major tenants;
difficulties in completing and successfully integrating acquisitions;
failure of acquisitions or development projects to occur at anticipated
levels or to yield anticipated results; risks associated with actual or
threatened terrorist attacks; intense competition in the real estate
market that may limit our ability to attract or retain tenants or
re-lease space; insufficient amounts of insurance or exposure to events
that are either uninsured or underinsured; uncertainties and risks
related to adverse weather conditions, natural disasters and climate
change; exposure to liability relating to environmental and health and
safety matters; limited ability to dispose of assets because of the
relative illiquidity of real estate investments and the nature of our
assets; exposure to litigation or other claims; risks associated with
breaches of our data security; risks associated with our indebtedness;
and other risks and uncertainties detailed in the “Risk Factors” section
of our Form 10-K for the year ended December 31, 2018, filed with the
Securities and Exchange Commission on February 28, 2019 and under the
heading “Risk Factors” in our other public filings.
In addition,
our anticipated qualification as a real estate investment trust involves
the application of highly technical and complex provisions of the
Internal Revenue Code of 1986, or the Code, and depends on our ability
to meet the various requirements imposed by the Code through actual
operating results, distribution levels and diversity of stock ownership.

We assume no obligation to update publicly any forward looking
statements, whether as a result of new information, future events or
otherwise.

 

Balance Sheet

 

(Unaudited, in thousands, except share amounts)

         
March 31, 2019 December 31, 2018
Assets
Real estate properties, net $ 1,771,788 $ 1,626,617
Cash and cash equivalents 8,663 6,854
Restricted cash 4,662 4,251
Deposits on acquisitions 3,250 7,070
Rents receivable 23,505 21,140
Accounts receivable 13,650 11,690
Deferred financing, net 2,281 2,459
Intangible assets, net 170,157 165,668
Interest rate swaps 3,147 4,563
Prepaid expenses and other assets   15,638   11,238
Total assets $ 2,016,741 $ 1,861,550
 
Liabilities
Revolving credit facility 184,500 134,750
Term loan facilities, net 248,329 248,238
Notes payable, net 173,804 173,778
Mortgage notes payable, net 208,780 209,589
Intangible liabilities, net 29,936 30,835
Interest rate swaps 3,398 1,797
Accounts payable and accrued liabilities   38,248   37,310
Total liabilities   886,995   836,297
 
Equity

Common stock, par value $0.01, 200,000,000 shares authorized,
68,005,907 and 60,849,206 shares issued and outstanding at March
31, 2019 and December 31, 2018, respectively.

680 608
Additional paid-in capital 1,127,938 1,017,415
Retained earnings 12,381 12,831
Cumulative dividends (154,944 ) (139,103 )
Accumulated other comprehensive income (loss)   (219 )   2,412
Total stockholders’ equity   985,836   894,163
Non-controlling interest in Operating Partnership   143,910   131,090
Total equity   1,129,746   1,025,253
Total liabilities and equity $ 2,016,741 $ 1,861,550
 
 

Income Statement

 

(Unaudited, in thousands, except share and per share amounts)

 
      Three Months Ended
March 31, 2019     March 31, 2018
Revenues
Rental income $ 48,488 $ 34,831
Tenant reimbursements 1,584 941
Other income   535   202
Total revenues   50,607   35,974
 
Expenses
Property operating 9,963 6,560
Real estate taxes 5,755 3,700
Depreciation and amortization 22,451 14,634
Acquisition costs 470 224
Corporate general and administrative   4,317   3,459
Total expenses   42,956   28,577
 
Other expenses
Interest expense, net   (8,132 )   (5,582 )
Net income (loss) (481 ) 1,815
 
Non-controlling interest in Operating Partnership 65 (296 )

 

       

Net income (loss) available to Easterly Government Properties,
Inc.

$ (416 ) $ 1,519
 

Net income (loss) available to Easterly Government Properties,
Inc. per share:

Basic $ (0.01 ) $ 0.03
Diluted $ (0.01 ) $ 0.03
 
Weighted-average common shares outstanding:
Basic 61,225,926 45,008,062
Diluted 61,225,926 46,018,040
 
Net income (loss), per share – fully diluted basis $ (0.01 ) $ 0.03
 
Weighted average common shares outstanding –

fully diluted basis

70,831,727 53,813,881
 
 

EBITDA, FFO and CAD

 

(Unaudited, in thousands, except share and per share amounts)

 
      Three Months Ended
March 31, 2019     March 31, 2018
Net income (loss) $ (481 ) $ 1,815
Depreciation and amortization 22,451 14,634
Interest expense   8,132   5,582
EBITDA $ 30,102 $ 22,031
 
Pro forma adjustments(1)   793
Pro forma EBITDA $ 30,895
 
Net income (loss) $ (481 ) $ 1,815
Depreciation and amortization   22,451   14,634
Funds From Operations (FFO) $ 21,970 $ 16,449
Adjustments to FFO:
Acquisition costs 470 224
Straight-line rent and other non-cash adjustments (974 ) (1,794 )
Above-/below-market leases (1,729 ) (2,279 )
Non-cash interest expense 322 264
Non-cash compensation   734   864
Funds From Operations, as Adjusted $ 20,793 $ 13,728
 
 
FFO, per share – fully diluted basis $ 0.31 $ 0.31
FFO, as Adjusted, per share – fully diluted basis $ 0.29 $ 0.26
 
Funds From Operations, as Adjusted $ 20,793 $ 13,728
Acquisition costs (470 ) (224 )
Principal amortization (836 ) (763 )
Maintenance capital expenditures (902 ) (466 )
Contractual tenant improvements   (38 )   (95 )
Cash Available for Distribution (CAD) $ 18,547 $ 12,180
 
Weighted average common shares outstanding –
fully diluted basis 70,831,727 53,813,881
 
1 Pro-forma assuming a full quarter of operations from
the three properties acquired in the first quarter of 2019.
 
     
March 31, 2019
Total Debt(1) $ 819,810
Less: Cash and cash equivalents   (8,663 )
Net Debt $ 811,147
Less: Adjustment for projects under construction(2)   (59,949 )
Adjusted Net Debt $ 751,198
 
1 Excludes unamortized premiums / discounts and deferred
financing fees.
2 See definition of Adjusted Net Debt on Page 4.
 

Contacts

Easterly Government Properties, Inc.
Lindsay S. Winterhalter
Vice
President, Investor Relations & Operations
202-596-3947
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading

Cannabis

Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania